Abstract |
Thai patients enrolled in STACCATO with HIV/hepatitis B virus (HBV) co-infection and tenofovir/ emtricitabine-based antiretroviral therapy (ART) were randomly assigned to continuous treatment or CD4 cell count-guided interruptions. HBV replication was suppressed below detection in 15/16 patients. Structured treatment interruption increased transaminases and HBV viraemia in five of six patients; one flare was severe. Conversion to anti- hepatitis Be occurred with continuous treatment only. Tenofovir/ emtricitabine-containing ART is highly effective in controlling chronic HIV/HBV co-infection but treatment should not be interrupted.
|
Authors | Reto Nüesch, Jintanat Ananworanich, Preeyaporn Srasuebkul, Ploenchan Chetchotisakd, Wisit Prasithsirikul, Wirat Klinbuayam, Apicha Mahanontharit, Thidarat Jupimai, Kiat Ruxrungtham, Bernard Hirschel |
Journal | AIDS (London, England)
(AIDS)
Vol. 22
Issue 1
Pg. 152-4
(Jan 02 2008)
ISSN: 1473-5571 [Electronic] England |
PMID | 18090405
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Retroviral Agents
- Antiviral Agents
- Hepatitis B e Antigens
- Organophosphonates
- Deoxycytidine
- Tenofovir
- Transaminases
- Emtricitabine
- Adenine
|
Topics |
- Adenine
(administration & dosage, analogs & derivatives)
- Anti-Retroviral Agents
(administration & dosage)
- Antiretroviral Therapy, Highly Active
- Antiviral Agents
(administration & dosage)
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Drug Administration Schedule
- Emtricitabine
- Female
- HIV
- HIV Infections
(complications, drug therapy)
- Hepatitis B e Antigens
(blood)
- Hepatitis B virus
(immunology, isolation & purification)
- Hepatitis B, Chronic
(blood, complications, drug therapy, virology)
- Humans
- Male
- Organophosphonates
(administration & dosage)
- Tenofovir
- Thailand
- Transaminases
(blood)
- Treatment Outcome
- Viral Load
|